Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
11/2000
11/09/2000WO2000066621A1 Peptides from the tt virus sequence and monospecific antibodies binding to the tt virus
11/09/2000WO2000066587A2 Polyamines and their use in therapy
11/09/2000WO2000066528A2 Quinones for treatment of diseases
11/09/2000WO2000066175A2 Conjugates as therapies for cancer and prostate diseases
11/09/2000WO2000032794A3 Chlamydia antigens and corresponding dna fragments and uses thereof
11/09/2000WO2000031123A3 Retro-inversion peptides that target gastro-intestinal tract transport receptors and use thereof
11/09/2000WO2000029428A3 5t4 tumour-associated antigen for use in tumour immunotherapy
11/09/2000DE19920816A1 Cephaibole, neue Antiparasitika aus Acremonium tubakii, Verfahren zu ihrer Herstellung und Verwendung derselben Cephaibols new antiparasitic drugs from Acremonium tubakii, processes for their preparation and use thereof
11/09/2000CA2372611A1 Quinones for treatment of diseases
11/09/2000CA2370495A1 Peptides from the tt virus sequence and monospecific antibodies binding to the tt virus
11/09/2000CA2368801A1 Conjugates as therapies for cancer and prostate diseases
11/08/2000EP1049714A1 Secreted proteins and polynucleotides encoding them
11/08/2000EP1049710A1 Peptides with beta-1 integrin subunit dependent cell adhesion modulating activity
11/08/2000EP1049709A1 Novel peptides having biological activity
11/08/2000EP1049481A2 Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same
11/08/2000EP1049450A1 Skin and hair darkening composition
11/08/2000EP0687180B1 Methods for detection and treatment of individuals having abnormal cells expressing hla-a2/tyrosinase peptide antigens
11/07/2000US6143901 Complex formation between dsDNA and pyrrole imidazole polyamides
11/07/2000US6143864 Peptides
11/07/2000US6143739 Antimicrobial agents mainly active against gram positive bacteria
11/07/2000US6143722 To controll uterine contractions in treating preterm labor
11/07/2000US6143721 For treating cancer in mammals
11/07/2000US6143719 Bradykinin analogs as selective thrombin inhibitors
11/07/2000US6143716 Liposomal peptide-lipid conjugates and delivery using same
11/07/2000US6143715 For treating and prevention of hepatitis c viurs infections
11/07/2000US6143511 Contacting nonhydrolyzed body fluid sample with first and second antibodies to form complex, detecting presence or amount of complex, wherein antibodies bind to telopeptide having sequence identical to that produced in vivo
11/07/2000US6143509 Prostate specific antigen peptides and uses thereof
11/07/2000US6143497 Synthesizing random oligomers on particles using identification tags to facilitate identification of sequence of monomers
11/07/2000US6143493 HCMV-specific peptides, agents therefor and the use thereof
11/07/2000CA2180657C Synthetic antimicrobial peptides
11/07/2000CA2024767C Interferon-gamma receptor fragment and its production
11/02/2000WO2000064927A1 Cyclic hexapeptides having antibiotic activity
11/02/2000WO2000064484A2 Conjugate having a cleavable linkage for use in a liposome
11/02/2000EP1047708A1 Peptide chelators that predominately form a single stereoisomeric species upon coordination to a metal center
11/02/2000EP1047441A1 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
11/02/2000EP1047301A1 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (prrsv)
11/02/2000EP0914331B1 Neuroactive peptides
11/01/2000CN1058020C Angiotensin converting enzyme inhibitor and method for preparing same
10/2000
10/31/2000US6140493 Method of synthesizing diverse collections of oligomers
10/31/2000US6140466 Comprises at least three zinc finger domains that bind to target cellular nucleotide sequence and modulate its transcription; genome-specific transcriptional switches in gene therapy; transgenic plants and animals
10/31/2000US6140120 Regulated transcription of targeted genes and other biological events
10/31/2000US6140081 Nucleotide binding polypeptide; for efficient use as diagnostic tools in gene therapy and transgenic cells
10/31/2000US6140066 Methods of cancer diagnosis using a chimeric toxin
10/26/2000WO2000063702A1 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes
10/26/2000WO2000063345A1 PSEUDOMYCIN PRODUCTION BY $i(PSEUDOMONAS SYRINGAE)
10/26/2000WO2000063249A1 Polypeptides derived from endostatin exhibiting antiangiogenic activity
10/26/2000WO2000063247A2 Osteopontin-derived chemotactic and inhibitory agents and uses therefor
10/26/2000WO2000063246A2 Compounds and methods for modulating beta-catenin mediated gene expression
10/26/2000WO2000063240A1 ANTIFUNGAL AGENTS ISOLATED FROM $i(PSEUDOMONAS SYRINGAE)
10/26/2000WO2000063239A1 Novel antifungal compounds
10/26/2000WO2000063237A2 Pseudomycin analogs
10/26/2000WO2000063236A2 Adhesion modulatory peptides and methods for use
10/26/2000WO2000063235A2 Materials and methods useful for the control of insect larvae
10/26/2000WO2000063233A2 Peptides and the use thereof to control pests
10/26/2000WO2000062791A1 D-form polypeptide which induces immune tolerance and methods of use
10/26/2000WO2000062620A2 Transformed cells useful for the control of pests
10/26/2000WO2000062615A1 Neuropeptides and their use for pest control
10/26/2000WO2000047607B1 A synthetic peptide disturbing intracellular signaling
10/26/2000WO2000034315A8 Purification of echinocandin cyclopeptide compounds
10/26/2000WO2000018795A3 Compositions and methods for wt1 specific immunotherapy
10/26/2000WO2000011032A9 Method for producing biostatin (tt-232 triacetate) and analogs thereof
10/26/2000CA2758956A1 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes
10/26/2000CA2371363A1 Antifungal agents isolated from pseudomonas syringae
10/26/2000CA2370313A1 Materials and methods useful for the control of insect larvae
10/26/2000CA2370301A1 Osteopontin-derived chemotactic and inhibitory agents and uses therefor
10/26/2000CA2370239A1 Pseudomycin production by pseudomonas syringae
10/26/2000CA2369961A1 Polypeptides derived from endostatin exhibiting antiangiogenic activity
10/26/2000CA2369136A1 Pseudomycin natural products
10/26/2000CA2368839A1 D-form polypeptide which induces immune tolerance and methods of use
10/26/2000CA2367938A1 Peptides and the use thereof to control pests
10/26/2000CA2365949A1 Adhesion modulatory peptides and methods for use
10/26/2000CA2365220A1 Transformed cells useful for the control of pests
10/25/2000EP1046650A1 PEPTIDES, METHOD FOR ASSAYING HUMAN PEPSINOGEN II or HUMAN PEPSIN II, AND ASSAYING KIT
10/25/2000EP1046421A2 Methods and reagents for very large scale immobilized polymer synthesis
10/25/2000EP1045861A1 Antibody/receptor targeting moiety for enhanced delivery of armed ligand
10/25/2000EP1045858A1 Anti-cryptococcal peptides
10/25/2000EP0736039B1 Compounds with growth hormone releasing properties
10/24/2000US6136787 Interleukin 1β protease and interleukin 1β protease inhibitors
10/24/2000US6136781 LH-RH receptor antagonists
10/24/2000US6136269 Combinatorial kit for polymer synthesis
10/24/2000CA2005955C Synthetic hiv-like peptides, their compositions and uses
10/19/2000WO2000061813A1 A second mammalian tankyrase
10/19/2000WO2000061789A1 Methods and reagents for determining enzyme substrate specificity, and uses related thereto
10/19/2000WO2000061766A2 Telomerase-specific cancer vaccine
10/19/2000WO2000061618A1 Fab-EPITOPE COMPLEX FROM THE HIV-1 CROSS-NEUTRALIZING MONOCLONAL ANTIBODY 2F5
10/19/2000WO2000061194A2 Short-chain peptide dye conjugates used as contrast agents for optical diagnostics
10/19/2000WO2000036093A3 Intein-mediated cyclization of peptides
10/19/2000WO2000034308A3 Protein transduction system and methods of use thereof
10/19/2000WO2000032769A3 Mage-10 or mage-8 derived hla-a2.1-binding oligopeptides
10/19/2000DE19917713A1 Kurzkettige Peptid-Farbstoffkonjugate als Konstrastmittel für die optische Diagnostik Short-chain peptide-dye conjugates as contrast agents for optical diagnostics
10/19/2000CA2371929A1 Fab'-epitope complex from the hiv-1 cross-neutralizing monoclonal antibody 2f5
10/19/2000CA2368490A1 Short-chain peptide dye conjugates used as contrast agents for optical diagnostics
10/19/2000CA2366671A1 Methods and reagents for determining enzyme substrate specificity, and uses related thereto
10/19/2000CA2360318A1 A second mammalian tankyrase
10/18/2000CN1270175A Disinfecting/permeability improved peptide allosteric in protein function region
10/17/2000US6133463 For use in cosmetic and dermatological compositions for treating or caring for the skin
10/17/2000US6133418 Synthetic peptide inhibitors of HIV transmission
10/17/2000US6132987 Polypeptide associated with macrophages; for diagnosis and treatment of inflammation, arthritis and atherosclerosis
10/17/2000US6132980 Antibodies specific for TRP-2 a human tumor antigen recognized by cytotoxic T lymphocytes
10/17/2000US6132720 Immunogens against gonadotropin releasing hormone
1 ... 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 ... 423